全文获取类型
收费全文 | 9412篇 |
免费 | 571篇 |
国内免费 | 29篇 |
专业分类
耳鼻咽喉 | 243篇 |
儿科学 | 510篇 |
妇产科学 | 99篇 |
基础医学 | 939篇 |
口腔科学 | 190篇 |
临床医学 | 788篇 |
内科学 | 2103篇 |
皮肤病学 | 219篇 |
神经病学 | 708篇 |
特种医学 | 279篇 |
外科学 | 1647篇 |
综合类 | 96篇 |
一般理论 | 4篇 |
预防医学 | 582篇 |
眼科学 | 240篇 |
药学 | 663篇 |
中国医学 | 16篇 |
肿瘤学 | 686篇 |
出版年
2023年 | 83篇 |
2022年 | 194篇 |
2021年 | 423篇 |
2020年 | 243篇 |
2019年 | 299篇 |
2018年 | 386篇 |
2017年 | 277篇 |
2016年 | 296篇 |
2015年 | 358篇 |
2014年 | 503篇 |
2013年 | 530篇 |
2012年 | 797篇 |
2011年 | 787篇 |
2010年 | 414篇 |
2009年 | 360篇 |
2008年 | 563篇 |
2007年 | 569篇 |
2006年 | 492篇 |
2005年 | 406篇 |
2004年 | 361篇 |
2003年 | 365篇 |
2002年 | 263篇 |
2001年 | 78篇 |
2000年 | 73篇 |
1999年 | 78篇 |
1998年 | 60篇 |
1997年 | 51篇 |
1996年 | 52篇 |
1995年 | 40篇 |
1994年 | 29篇 |
1993年 | 25篇 |
1992年 | 36篇 |
1991年 | 31篇 |
1990年 | 32篇 |
1989年 | 28篇 |
1988年 | 39篇 |
1987年 | 27篇 |
1986年 | 33篇 |
1985年 | 30篇 |
1984年 | 20篇 |
1983年 | 24篇 |
1982年 | 25篇 |
1981年 | 23篇 |
1980年 | 16篇 |
1979年 | 18篇 |
1978年 | 14篇 |
1977年 | 18篇 |
1976年 | 14篇 |
1973年 | 16篇 |
1972年 | 18篇 |
排序方式: 共有10000条查询结果,搜索用时 9 毫秒
1.
Raymond J. Chan RN PhD Vivienne E. Milch MBBS MHPol Fiona Crawford-Williams PhD Oluwaseyifunmi Andi Agbejule BRadTherapy Ria Joseph MNutrDiet Jolyn Johal BND Narayanee Dick BSc Matthew P. Wallen PhD Julie Ratcliffe PhD Anupriya Agarwal MBBS Larissa Nekhlyudov MD Matthew Tieu PhD Manaf Al-Momani BPharm Scott Turnbull PhD Rahul Sathiaraj MPH Dorothy Keefe MBBS MD Nicolas H. Hart PhD 《CA: a cancer journal for clinicians》2023,73(6):565-589
Patient navigation is a strategy for overcoming barriers to reduce disparities and to improve access and outcomes. The aim of this umbrella review was to identify, critically appraise, synthesize, and present the best available evidence to inform policy and planning regarding patient navigation across the cancer continuum. Systematic reviews examining navigation in cancer care were identified in the Cochrane Central Register of Controlled Trials (CENTRAL), PubMed, Embase, Cumulative Index of Nursing and Allied Health (CINAHL), Epistemonikos, and Prospective Register of Systematic Reviews (PROSPERO) databases and in the gray literature from January 1, 2012, to April 19, 2022. Data were screened, extracted, and appraised independently by two authors. The JBI Critical Appraisal Checklist for Systematic Review and Research Syntheses was used for quality appraisal. Emerging literature up to May 25, 2022, was also explored to capture primary research published beyond the coverage of included systematic reviews. Of the 2062 unique records identified, 61 systematic reviews were included. Fifty-four reviews were quantitative or mixed-methods reviews, reporting on the effectiveness of cancer patient navigation, including 12 reviews reporting costs or cost-effectiveness outcomes. Seven qualitative reviews explored navigation needs, barriers, and experiences. In addition, 53 primary studies published since 2021 were included. Patient navigation is effective in improving participation in cancer screening and reducing the time from screening to diagnosis and from diagnosis to treatment initiation. Emerging evidence suggests that patient navigation improves quality of life and patient satisfaction with care in the survivorship phase and reduces hospital readmission in the active treatment and survivorship care phases. Palliative care data were extremely limited. Economic evaluations from the United States suggest the potential cost-effectiveness of navigation in screening programs. 相似文献
2.
Fahad Ali Rahul Smita Jyoti Ambreen Fatima Saba Khanam Falaq Naz Yasir Hasan Siddique 《Scientia pharmaceutica》2016,84(2):361-377
The present investigation was aimed at studying the possible role of curcumin against N-nitrosodiethylamine (NDEA)-induced toxicity in albino rats. Administration of NDEA to rats at a concentration of 0.1 mg/ml in drinking water ad libitum for 21 days produced toxicity in them, which was evident from histopathological changes in the rat livers, and increased levels of blood serum enzyme markers, i.e. aspartate transaminase, alanine transaminase, alkaline phosphatase, and lactate dehydrogenase. In addition, the levels of oxidative stress markers like lipid peroxidation (LPO), protein carbonyl (PCC), and glutathione-S-transferase (GST) activity were elevated and the total glutathione (GSH) content was reduced in the livers. The administration of curcumin to rats at concentrations of 10, 20, and 40 mg/ml in drinking water along with 0.1 mg/ml of NDEA for 21 days effectively suppressed NDEA-induced toxicity and also resulted in a dose-dependent reduction in the levels of blood serum enzyme markers (AST, ALT, ALP, and LDH). Moreover, LPO, PCC, and GST activity were reduced and the GSH level was increased upon the administration of curcumin along with NDEA. The results obtained for the comet assay in rat hepatocytes and blood lymphocytes showed a significant dose-dependent decrease in the mean tail length. The micronucleus assay performed on rat hepatocytes also showed a dose-dependent reduction in the frequency of micronucleated cells along with curcumin administration. These results suggest that curcumin has a protective role against NDEA-induced toxicity in albino rats. 相似文献
3.
Joseph F. Levy Rahul Khairnar Alexander V. Louie Timothy N. Showalter C. Daniel Mullins Mark V. Mishra 《Practical radiation oncology》2019,9(2):e172-e179
Purpose
A hydrogel rectal spacer (HRS) is a medical device that is approved by the U.S. Food and Drug Administration to increase the separation between the prostate and rectum. We conducted a cost-effectiveness analysis of HRS use for reduction in radiation therapy (RT) toxicities in patients with prostate cancer (PC) undergoing external beam RT (EBRT).Methods and Materials
A multistate Markov model was constructed from the U.S. payer perspective to examine the cost-effectiveness of HRS in men with localized PC receiving EBRT (EBRT alone vs EBRT + HRS). The subgroups analyzed included site of HRS placement (hospital outpatient, physician office, ambulatory surgery center) and proportion of patients with good baseline erectile function (EF). Data on EF, gastrointestinal and genitourinary toxicities incidence, and potential risks associated with HRS implantation were obtained from a recently published randomized clinical trial. Health utilities and costs were derived from the literature and the 2018 Physician Fee Schedule and were discounted 3% annually. Quality-adjusted life years (QALYs) and costs were modeled for a 5-year period from receipt of RT. Probabilistic sensitivity analysis and value-based threshold analyses were conducted.Results
The per-patient 5-year incremental cost for spacers administered in a hospital outpatient setting was $3578, and the incremental effectiveness was 0.0371 QALYs. The incremental cost-effectiveness ratio was $96,440/QALY for patients with PC undergoing HRS insertion in a hospital and $39,286/QALY for patients undergoing HRS insertion in an ambulatory facility. For men with good baseline EF, the incremental cost-effectiveness ratio was $35,548/QALY and $9627/QALY in hospital outpatient and ambulatory facility settings, respectively.Conclusions
Based on the current Medicare Physician Fee Schedule, HRS is cost-effective at a willingness to pay threshold of $100,000. These results contain substantial uncertainty, suggesting more evidence is needed to refine future decision-making. 相似文献4.
5.
6.
7.
Factors associated with the quality of laboratory performance in the United Kingdom external quality assessment scheme for serum growth hormone 总被引:1,自引:0,他引:1
J Seth I Hanning 《Clinica chimica acta; international journal of clinical chemistry》1988,174(2):185-195
A search was made for associations between poor performance in the UK External Quality Assessment Scheme (EQAS) for serum growth hormone (GH), and a range of factors including assay method, laboratory workload and staffing, and Internal Quality Control (IQC) procedures. On the basis of the factors identified as being associated with poor performance we recommend the following. 1. Laboratories using RIA for GH should routinely analyse samples at two dilutions and report a mean result. 2. The use of 125I-GH which is 5 or more weeks old should be avoided. Tracer should also be chromatographed to remove aggregate before use. 3. Laboratories using RIA should avoid using a standard curve which covers too wide a range concentration; a curve midpoint (ie GH concentration to reduce the zero standard binding by 50%) of about 8 mU/l or less is probably acceptable. 4. It should be noted that high workloads present a risk of some loss in quality of responsible for checking IQC data. 6. Laboratories which do not have the resources to maintain fully their own RIA as outlined above should carefully consider use of an unbiased, precise IRMA. The UK EQAS has identified two assays (Boots-Celltech Sucrosep, NETRIA) that appear to meet these criteria [2]. The above observations may also be relevant to immunoassays for other peptide hormones. 相似文献
8.
L. K. Kochhar V. K. Shukul Rahul Sharma 《Indian journal of otolaryngology and head and neck surgery》2004,56(1):49-50
All penetrating neck wounds are potentially very dangerous and require emergency treatment. The choice of treatment for the
stable patient remains controversial, a number of studies encouraging mandatory surgical exploration and a similar number
encourage selective surgical exploration. Knowledge of the physical properties of the penetrating object or weapon can help
to determine a treatment plan and predict the risk of injury- All tracheal and esophageal injuries with structural damage
should be repaired primarily. A case of Gun Shot Wound Neck was air evacuated to Army Hospital R & R Delhi Cantt in a tracheostomised
state. Patient was evaluated in detail, he had trachea esophageal fistula. The management of this case is discussed along
with principles of management of war injuries. 相似文献
9.
10.
Genetic variation in serotonin transporter alters resting brain function in healthy individuals. 总被引:1,自引:0,他引:1
Hengyi Rao Seth J Gillihan Jiongjiong Wang Marc Korczykowski Geena Mary V Sankoorikal Kristin A Kaercher Edward S Brodkin John A Detre Martha J Farah 《Neuropsychopharmacology》2007,62(6):600-606
BACKGROUND: Perfusion functional magnetic resonance imaging (fMRI) was used to investigate the effect of genetic variation of the human serotonin transporter (5-HTT) gene (5-HTTLPR, SLC6A4) on resting brain function of healthy individuals. METHODS: Twenty-six healthy subjects, half homozygous for the 5-HTTLPR short allele (s/s group) and half homozygous for the long allele (l/l group), underwent perfusion functional and structural magnetic resonance imaging during a resting state. The two genotype groups had no psychiatric illness and were similar in age, gender, and personality scores. RESULTS: Compared with the l/l group, the s/s group showed significantly increased resting cerebral blood flow (CBF) in the amygdala and decreased CBF in the ventromedial prefrontal cortex. The effect of functional modulation in these regions by 5-HTTLPR genotype cannot be accounted for by variations in brain anatomy, personality, or self-reported mood. CONCLUSIONS: The 5-HTTLPR genotype alters resting brain function in emotion-related regions in healthy individuals, including the amygdala and ventromedial prefrontal cortex. Such alterations suggest a broad role of the 5-HTT gene in brain function that may be associated with the genetic susceptibility for mood disorders such as depression. 相似文献